Literature DB >> 22236182

Role of pharmacists in the management of patients with epilepsy.

Samuel Koshy1.   

Abstract

OBJECTIVES: The aim of this article is to highlight the roles that pharmacists currently have in the management of patients with epilepsy and the opportunities and challenges associated with these roles. KEY
FINDINGS: There are many opportunities for pharmacists in the management of patients with epilepsy owing to the accessibility and extensive knowledge of drug therapy. The role of pharmacists extends beyond dispensing medications. The pharmacists have a significant role in the education of patients about the disease and therapy, encouraging adherence and explaining side effects and providing information on potential drug-drug interactions, resulting in improved clinical outcomes and decreased costs. Physicians prefer pharmacists as information sources for medication profile and drug interaction screening for patients with epilepsy. However, there are certain challenges which the pharmacists should overcome if effective medication therapy management services are to be provided on a routine basis. Educational interventions are required to improve the knowledge and skills of pharmacists. The gap between patients' and pharmacists' views of the pharmacist's role has to be narrowed to ensure enhanced role of the pharmacists in this patient group.
CONCLUSIONS: There are a lot of opportunities and challenges for pharmacists to provide medication therapy management services for patients with epilepsy. Evidence in the literature provides justification for such services. However more research is required to provide foundation for routine provision of such services in all healthcare facilities.
© 2011 The Author. IJPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22236182     DOI: 10.1111/j.2042-7174.2011.00156.x

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  6 in total

1.  Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.

Authors:  Anna Paula de Sá Borges; Marília Silveira de Almeida Campos; Leonardo Régis Leira Pereira
Journal:  Int J Clin Pharm       Date:  2013-02-21

2.  Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study).

Authors:  Martha Losada-Camacho; Mario F Guerrero-Pabon; Pilar Garcia-Delgado; Fernando Martínez-Martinez
Journal:  Health Qual Life Outcomes       Date:  2014-10-31       Impact factor: 3.186

3.  Quality Indicators of Pharmaceutical Care in Palestinian Integrative Healthcare Facilities: Findings of a Qualitative Study among Stakeholders.

Authors:  Ramzi Shawahna
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-10       Impact factor: 2.629

4.  Quality Indicators of Pharmaceutical Care for Integrative Healthcare: A Scoping Review of Indicators Developed Using the Delphi Technique.

Authors:  Ramzi Shawahna
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-19       Impact factor: 2.629

5.  Role of clinical pharmacists in epilepsy management at a general hospital in Vietnam: a before-and-after study.

Authors:  Hong Tham Pham; Minh-Hoang Tran; Ngoc Quy Nguyen; Van Tan Vo; Manh Hung Tran
Journal:  J Pharm Policy Pract       Date:  2021-12-20

6.  A Survey of Canadian Pharmacists' Knowledge and Comfort in the Management of Epilepsy and Antiepileptic Drugs.

Authors:  Akshita Chandok; Sherif Hanafy Mahmoud
Journal:  J Pharm Technol       Date:  2022-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.